Treatment of childhood nephrotic syndrome with long-term, low-dose tacrolimus.

Conclusion: Our results demonstrate that TAC treatment for children with SR/SD NS is associated with high rates of sustained remission, even when prior second-line agents failed.
PMID: 23380387 [PubMed - as supplied by publisher]

Source: Clinical Nephrology - February 5, 2013 Category: Urology & Nephrology Authors: Bock ME, Cohn RA, Ali FN Tags: Clin Nephrol Source Type: research